capsaicin

(redirected from Qutenza)
Also found in: Dictionary, Thesaurus, Medical.

capsaicin

[kap′sā·ə·sən]
(organic chemistry)
C18H27O3N A toxic material extracted from capsicum.
Mentioned in ?
References in periodicals archive ?
The high-dose capsaicin (8%) containing dermal patch Qutenza (Rx) was developed by NeurogesX and licensed to Astellas Pharma Europe in 2009.
Grunenthal will hold exclusive rights for Qutenza in all 28 European Union member states, Switzerland, Iceland, Norway and Lichtenstein, and other East European, Middle East and African countries.
Qutenza is reportedly approved by the US Food and Drug Administration (FDA) for the management of neuropathic pain associated with postherpetic neuralgia.
NeurogesX believes that this facility, together with the USD20m equity private placement completed on 26 July 2011, gives the company the necessary cash to take it into 2013 and enables it to pursue strategic activities that could further support the advancement of Qutenza and NGX-1998, said Stephen Ghiglieri, executive VP, COO and CFO.
2m in collaboration revenue and USD844,000 from Qutenza US revenue recognition, was generated for the second quarter ended 30 June 2012.
Proceeds from the agreement are expected to be used by the company to further support commercialisation activities of its Qutenza (capsaicin) 8% patch, the clinical development of its lead product candidate NGX-1998 and for general corporate purposes.